BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8598330)

  • 21. Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix.
    Goyal A; Yang B
    Int J Gynecol Pathol; 2014 Nov; 33(6):613-9. PubMed ID: 25272301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesonephric remnants of the prostate: incidence and histologic spectrum.
    Bostwick DG; Qian J; Ma J; Muir TE
    Mod Pathol; 2003 Jul; 16(7):630-5. PubMed ID: 12861057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum.
    Nucci MR; Clement PB; Young RH
    Am J Surg Pathol; 1999 Aug; 23(8):886-91. PubMed ID: 10435557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudoneoplastic glandular lesions of the uterine cervix: a selective review.
    Nucci MR
    Int J Gynecol Pathol; 2014 Jul; 33(4):330-8. PubMed ID: 24901392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation.
    Ordi J; Nogales FF; Palacin A; Márquez M; Pahisa J; Vanrell JA; Cardesa A
    Am J Surg Pathol; 2001 Dec; 25(12):1540-5. PubMed ID: 11717545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Squamous cell carcinoma in situ involving mesonephric remnants of the uterine cervix.
    Zámecník M
    Cesk Patol; 2004 Jul; 40(3):109-11. PubMed ID: 15493419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesonephric proliferations of the female genital tract.
    Howitt BE; Nucci MR
    Pathology; 2018 Feb; 50(2):141-150. PubMed ID: 29269124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases.
    Bagué S; Rodríguez IM; Prat J
    Am J Surg Pathol; 2004 May; 28(5):601-7. PubMed ID: 15105647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesonephric Adenocarcinoma of the Uterine Corpus: A Report on 2 Cases With Comparison to Its Cervical Counterpart.
    Liang Y; Shi H; Zhu X; Yu M; Zhang X
    Int J Gynecol Pathol; 2020 Nov; 39(6):546-551. PubMed ID: 31985582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesonephric adenocarcinoma of the uterine cervix: a case report with immunohistochemical and ultrastructural studies.
    Fukunaga M; Takahashi H; Yasuda M
    Pathol Res Pract; 2008; 204(9):671-6. PubMed ID: 18374498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesonephric adenocarcinoma in the uterine corpus: A case report and review of the literature.
    Tang X; Li L; He Y
    Indian J Pathol Microbiol; 2021; 64(4):806-809. PubMed ID: 34673610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervical Mesonephric Adenocarcinoma With Novel FGFR2 Mutation.
    Skala SL; Gregg PA; Orr JW; Udager AM; Brown NA; Cho KR
    Int J Gynecol Pathol; 2020 Sep; 39(5):452-455. PubMed ID: 31335448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Florid hyperplasia of mesonephric remnants involving prostate and periprostatic tissue. Possible confusion with adenocarcinoma.
    Gikas PW; Del Buono EA; Epstein JI
    Am J Surg Pathol; 1993 May; 17(5):454-60. PubMed ID: 7682379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β.
    Kenny SL; McBride HA; Jamison J; McCluggage WG
    Am J Surg Pathol; 2012 Jun; 36(6):799-807. PubMed ID: 22456609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenoid basal epitheliomas of the uterine cervix: a reevaluation of distinctive cervical basaloid lesions currently classified as adenoid basal carcinoma and adenoid basal hyperplasia.
    Brainard JA; Hart WR
    Am J Surg Pathol; 1998 Aug; 22(8):965-75. PubMed ID: 9706976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesonephric rest hyperplasia. A potential diagnostic pitfall.
    Amin-Hanjani S; Paulson J; Henien S; Hanjani P
    Arch Pathol Lab Med; 1991 Oct; 115(10):1059-61. PubMed ID: 1898238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
    Chen YB; Fine SW; Epstein JI
    Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype.
    Mikami Y; Hata S; Melamed J; Fujiwara K; Manabe T
    Histopathology; 2001 Oct; 39(4):364-72. PubMed ID: 11683936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative differential diagnosis of minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia of the uterine cervix: a multicenter study of clinicopathology and magnetic resonance imaging findings.
    Takatsu A; Shiozawa T; Miyamoto T; Kurosawa K; Kashima H; Yamada T; Kaku T; Mikami Y; Kiyokawa T; Tsuda H; Ishii K; Togashi K; Koyama T; Fujinaga Y; Kadoya M; Hashi A; Susumu N; Konishi I
    Int J Gynecol Cancer; 2011 Oct; 21(7):1287-96. PubMed ID: 21685796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperplasia of prostatic mesonephric remnants: a potential pitfall in the evaluation of prostate gland biopsy.
    Val-Bernal JF; Gómez-Ortega JM
    J Urol; 1995 Sep; 154(3):1138-9. PubMed ID: 7543609
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.